3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
9
Genitourinary
4
Other solid neoplasm
1
CNS
1
Conditions
Childhood Solid Tumor
1
Interventions
pembrolizumab
30
Injections
26
Pemetrexed
15
Interviews as Topic
15
tislelizumab
13
Specimen Handling
13
Carboplatin
13
Cisplatin
12
Nivolumab
11
atezolizumab
10
Practice Guidelines as Topic
9
Educational Status
9
Cyclophosphamide
9
Bevacizumab
9
Standard of Care
8
Oxaliplatin
8
Fluorouracil
8
fludarabine
7
Methods
7
Early Intervention, Educational
7
Docetaxel
7
Cetuximab
7
Capecitabine
7
toripalimab
6
sotorasib
6
Platinum
6
Paclitaxel
6
Leucovorin
6
Ipilimumab
6
Gemcitabine
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Vinblastine
×
Other solid neoplasm
×
90 days
×
Clear all
NCT03585465
2026-05-29
Metro-PD1
Centre Oscar Lambret
Phase 1/2
Terminated
63 enrolled